相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Amanda B. Chai et al.
FEBS JOURNAL (2020)
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease
Tosha Williams et al.
MOLECULAR NEURODEGENERATION (2020)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Axel Montagne et al.
NATURE (2020)
Beyond the CNS: The many peripheral roles of APOE
Ana B. Martinez-Martinez et al.
NEUROBIOLOGY OF DISEASE (2020)
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Eva Gil-Martins et al.
PHARMACOLOGY & THERAPEUTICS (2020)
ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease
Maria Fe Lanfranco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition
Samantha C. Burnham et al.
NEUROBIOLOGY OF AGING (2020)
ApoE4: an emerging therapeutic target for Alzheimer's disease
Mirna Safieh et al.
BMC MEDICINE (2019)
APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1
Masaya Tachibana et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by AP0E4
Tina Bilousova et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition
Darrell Sawmiller et al.
BIOLOGICAL PSYCHIATRY (2019)
High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β
Shamasree Ghosh et al.
FEBS JOURNAL (2019)
Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
Yu-Wen Alvin Huang et al.
JOURNAL OF NEUROSCIENCE (2019)
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki et al.
NATURE REVIEWS NEUROLOGY (2019)
Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier
Dustin Chernick et al.
NEUROSCIENCE LETTERS (2019)
ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes
Varun Rawat et al.
JOURNAL OF NEUROSCIENCE (2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk
Iris E. Jansen et al.
NATURE GENETICS (2019)
ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
Ioannis Dafnis et al.
BIOCHEMICAL JOURNAL (2018)
The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis
E. Schmukler et al.
MOLECULAR NEUROBIOLOGY (2018)
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
Chengzhong Wang et al.
NATURE MEDICINE (2018)
The effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status
Walter Gulisano et al.
NEUROBIOLOGY OF AGING (2018)
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types
Yuan-Ta Lin et al.
NEURON (2018)
Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy
Shu-Hui Xin et al.
NEUROTOXICITY RESEARCH (2018)
Critical aggregation concentration for the formation of early Amyloid-β (1-42) oligomers
Mercedes Novo et al.
SCIENTIFIC REPORTS (2018)
The Physiological Roles of Amyloid-beta Peptide Hint at New Ways to Treat Alzheimer's Disease
Holly M. Brothers et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
Harald Steiner et al.
CELL STRESS (2018)
Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease
Fan Liao et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease
Kasper Planeta Kepp
JOURNAL OF ALZHEIMERS DISEASE (2017)
Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
Tien-Phat V. Huynh et al.
JOURNAL OF LIPID RESEARCH (2017)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Chia-Chen Liu et al.
NEURON (2017)
A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions
Carl Frieden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer's disease-like pathology
Tal Nuriel et al.
NATURE COMMUNICATIONS (2017)
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
Helene-Marie Lanoiselee et al.
PLOS MEDICINE (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline
Shan Liu et al.
SCIENTIFIC REPORTS (2017)
ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion
Yu-Wen Alvin Huang et al.
CELL (2017)
Central Nervous System Lipoproteins ApoE and Regulation of Cholesterol Metabolism
Robert W. Mahley
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity
Peng Yuan et al.
JOURNAL OF NEUROSCIENCE (2016)
The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific
Ioannis Dafnis et al.
SCIENTIFIC REPORTS (2016)
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta et al.
EBIOMEDICINE (2016)
Chemical Cross-Linking/Mass Spectrometry Maps the Amyloid β Peptide Binding Region on Both Apo lipoprotein E Domains
Stephanie Deroo et al.
ACS CHEMICAL BIOLOGY (2015)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
APOEε2 is associated with milder clinical and pathological Alzheimer disease
Alberto Serrano-Pozo et al.
ANNALS OF NEUROLOGY (2015)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
Jin Hu et al.
MOLECULAR NEURODEGENERATION (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Synaptic activity and Alzheimer's disease: a critical update
Davide Tampellini
FRONTIERS IN NEUROSCIENCE (2015)
Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer's Disease by Accelerating the Clearance of Amyloid-Beta
Qingxiang Song et al.
ACS NANO (2014)
Amyloid-β Efflux from the Central Nervous System into the Plasma
Kaleigh Filisa Roberts et al.
ANNALS OF NEUROLOGY (2014)
The role of amyloid-beta in the regulation of memory
John E. Morley et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
Kanchan Garai et al.
BIOCHEMISTRY (2014)
HDL and cholesterol handling in the brain
Cecilia Vitali et al.
CARDIOVASCULAR RESEARCH (2014)
Apolipoprotein E Isoforms and Lipoprotein Metabolism
Michael C. Phillips
IUBMB LIFE (2014)
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
Leon M. Tai et al.
MOLECULAR NEURODEGENERATION (2014)
Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
Yadong Huang et al.
NEUROBIOLOGY OF DISEASE (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
What are lipoproteins doing in the brian?
Hong Wang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function
Angel C. Y. Mak et al.
JAMA NEUROLOGY (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
The amyloid precursor protein: A biochemical enigma in brain development, function and disease
Natalia N. Nalivaeva et al.
FEBS LETTERS (2013)
Accelerated Progression from Mild Cognitive Impairment to Dementia Among APOE ε4ε4 Carriers
Wei-Li Xu et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Binding of Apolipoprotein E Inhibits the Oligomer Growth of Amyloid-β Peptide in Solution as Determined by Fluorescence Cross-correlation Spectroscopy
Sonny Ly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples
Leon M. Tai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
Adam S. Fleisher et al.
NEUROBIOLOGY OF AGING (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
Andrew B Wolf et al.
Alzheimers Research & Therapy (2013)
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex
Stephen Arold et al.
ACTA NEUROPATHOLOGICA (2012)
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β
Robert M. Koffie et al.
BRAIN (2012)
Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels
C. Y. Daniel Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms
Jie Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes
Jacob M. Basak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
Katherine L. Youmans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
Jungsu Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide
Tadafumi Hashimoto et al.
JOURNAL OF NEUROSCIENCE (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease
Aaron J. Trachtenberg et al.
NEUROBIOLOGY OF AGING (2012)
Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease
Carl Frieden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models
Yadong Huang
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Self-Association and Stability of the ApoE Isoforms at Low pH: Implications for ApoE-Lipid Interactions
Kanchan Garai et al.
BIOCHEMISTRY (2011)
High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease
Emilie Cerf et al.
FASEB JOURNAL (2011)
Blocking the Apolipoprotein E/Amyloid-beta Interaction Reduces Fibrillar Vascular Amyloid Deposition and Cerebral Microhemorrhages in TgSwDI Mice
Jing Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in an in Vitro Blood-Brain Barrier Model
Kazuchika Nishitsuji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E. Genin et al.
MOLECULAR PSYCHIATRY (2011)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions
Jianglei Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-β (Aβ) and acts in concert with Aβ to elicit neuronal and behavioral deficits in mice
Nga Bien-Ly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Accumulation of intraneuronal Aβ correlates with ApoE4 genotype
Ditte Z. Christensen et al.
ACTA NEUROPATHOLOGICA (2010)
Influence of apolipoprotein E ε4 on rates of cognitive and functional decline in mild cognitive impairment
Danielle C. Whitehair et al.
ALZHEIMERS & DEMENTIA (2010)
Astrocytic Aβ1-42 Uptake Is Determined by Aβ-Aggregation State and the Presence of Amyloid-Associated Proteins
Henrietta M. Nielsen et al.
GLIA (2010)
ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
James J. Donkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Apolipoprotein E-Dependent Accumulation of Alzheimer Disease-Related Lesions Begins in Middle Age
Eloise Kok et al.
ANNALS OF NEUROLOGY (2009)
Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism
Lingzhi Zhao et al.
JOURNAL OF NEUROSCIENCE (2009)
Human APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
Kelly R. Bales et al.
JOURNAL OF NEUROSCIENCE (2009)
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests
K. A. Bates et al.
MOLECULAR PSYCHIATRY (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease;: A case control study from central Norway
Sigrid B. Sando et al.
BMC NEUROLOGY (2008)
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
S. Cosentino et al.
NEUROLOGY (2008)
ApoE promotes the proteolytic degradation of Aβ
Qingguang Jiang et al.
NEURON (2008)
Apolipoprotein E and cholesterol in aging and disease in the brain
Elena Posse de Chaves et al.
FUTURE LIPIDOLOGY (2008)
Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease
Veronica Hirsch-Reinshagen et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease
David R. Riddell et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
Aβ40 inhibits amyloid deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2007)
Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease
Martin J. Sadowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
I. J. Martins et al.
MOLECULAR PSYCHIATRY (2006)
Apolipoprotein E structure: insights into function
Danny M. Hatters et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein
MJ LaDu et al.
BIOCHEMISTRY (2006)
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells:: ApoE structure as a potential therapeutic target
SM Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Fluorescence resonance energy transfer analysis of apolipoprotein E C-terminal domain and amyloid β peptide (1-42) interaction
MJ Phu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
RM Lane et al.
JOURNAL OF LIPID RESEARCH (2005)
Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease
JC Dodart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease
DK Lahiri et al.
NEUROBIOLOGY OF AGING (2004)
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of apolipoprotein E in lipid metabolism in the central nervous system
X Han
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Impact of APOE in mild cognitive impairment
MR Farlow et al.
NEUROLOGY (2004)
The effect of oxidative stress on amyloid precursor protein processing in cells engaged in β-amyloidosis is related to apolipoprotein E genotype
B Mazur-Kolecka et al.
ACTA NEUROPATHOLOGICA (2004)
Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-β protein into synaptic terminals
KH Gylys et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon 4 allele
DG Cook et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease
AM Fagan et al.
NEUROBIOLOGY OF DISEASE (2002)
Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurit eoutgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein
BP Nathan et al.
BRAIN RESEARCH (2002)
Lipid binding-induced conformational change in human apolipoprotein E - Evidence for two lipid-bound states on spherical particles
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation
HS Cho et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain
JA Morrow et al.
BIOCHEMISTRY (2000)
Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid β-peptide with the N-terminal, receptor binding domain of apolipoprotein E
AA Golabek et al.
BIOPHYSICAL JOURNAL (2000)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture
M Michikawa et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
